APA (7th ed.) Citation

Mao, C., Xiong, A., Qian, J., Wang, W., Liu, Y., Zhang, T., . . . Xu, N. (2024). Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: The first-in-human phase Ia/Ib study. Journal of Hematology & Oncology, 17(1), 1. https://doi.org/10.1186/s13045-024-01651-5

Chicago Style (17th ed.) Citation

Mao, Chenyu, et al. "Dual Inhibition of LAG-3 and PD-1 with IBI110 and Sintilimab in Advanced Solid Tumors: The First-in-human Phase Ia/Ib Study." Journal of Hematology & Oncology 17, no. 1 (2024): 1. https://doi.org/10.1186/s13045-024-01651-5.

MLA (9th ed.) Citation

Mao, Chenyu, et al. "Dual Inhibition of LAG-3 and PD-1 with IBI110 and Sintilimab in Advanced Solid Tumors: The First-in-human Phase Ia/Ib Study." Journal of Hematology & Oncology, vol. 17, no. 1, 2024, p. 1, https://doi.org/10.1186/s13045-024-01651-5.